Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Analytical Tool - Cancer Therapeutic Antibodies -' returned 111 results - Page 1 of 6   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Analytical Tool - Cancer Therapeutic Antibodies   Bioseeker, Feb 2012 Analytical Tool - Cancer Therapeutic Antibodies "Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies   Bioseeker, June 2006 Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies "Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast Triple Analysis: Breast Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3516 publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3926 Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody Triple Analysis: Breast Cancer, Lung Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 4180 Tool for Optimizing the Pipeline from Research To Market Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3441 Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody Triple Analysis: Colorectal Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3659 publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development Triple Analysis: Breast Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3695 Triple Analysis: Breast Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the compound Triple Analysis: Breast Cancer, Colorectal Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3913 Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development Triple Analysis: Lung Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 4105 Triple Analysis: Lung Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy Triple Analysis: Colorectal Cancer, Lung Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 4323 : Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Antibodies   Bioseeker, March 2012, Pages: 3706 publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development Triple Analysis: Colorectal Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3838 Triple Analysis: Colorectal Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the compound Triple Analysis: Lung Cancer, Pancreatic Cancer and Antibodies   Bioseeker, March 2012, Pages: 4370 Triple Analysis: Lung Cancer, Pancreatic Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies   Bioseeker, Sep 2011, Pages: 4709 indications. This part is based on the following publication: Protein Kinase Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part comprises defined Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies   Bioseeker, Sep 2011, Pages: 4045 Kinase Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies   Bioseeker, March 2012, Pages: 3885 Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the compound Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Antibodies   Bioseeker, March 2012, Pages: 4103 Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies   Bioseeker, Sep 2011, Pages: 4224 indications. This part is based on the following publication: Protein Kinase Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part comprises defined Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Antibodies   Bioseeker, Sep 2011, Pages: 4442 different cancer indications. This part is based on the following publication: Protein Kinase Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network